MetaADEDB 2.0 @ LMMD
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
(JVHXJTBJCFBINQ-ADAARDCZSA-N)
Structure
SMILES
CCOc1ccc(cc1)Cc1cc(ccc1Cl)[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O
Type(s)
Approved
ATC code(s)
A10BD15; A10BD21; A10BD25; A10BK01
Molecular Formula:
C21H25ClO6
Molecular Weight:
408.873
Log P:
1.8444
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
4
TPSA:
99.38
CAS Number(s):
461432-26-8
Synonym(s)
1.
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
2.
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
3.
BMS 512148
4.
BMS-512148
5.
BMS512148
6.
dapagliflozin
7.
forxiga
External Link(s)
MeSHC529054
PubChem Compound9887712
BindingDB20880
50448923
ChEBI85078
CHEMBLCHEMBL429910
DrugBankDB06292
DrugCentral4304
IUPHAR/BPS Guide to PHARMACOLOGY4594
KEGGdr:D08897
Therapeutic Target DatabaseD01TNW
ZINC3819138
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Diabetic KetoacidosisFAERS: 501
Canada Vigilance: 22
Canada Vigilance
US FAERS
2Weight decreasedFAERS: 180
Canada Vigilance: 2
Canada Vigilance
US FAERS
3Urinary tract infectionFAERS: 179
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
4KetoacidosisFAERS: 153
Canada Vigilance: 7
Canada Vigilance
US FAERS
5Blood glucose increasedFAERS: 119
Canada Vigilance: 2
Canada Vigilance
US FAERS
6MalaiseFAERS: 90
Canada Vigilance: 1
Canada Vigilance
US FAERS
7DizzinessFAERS: 89
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
8DehydrationFAERS: 85SIDER
US FAERS
9NauseaFAERS: 75
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
10HeadacheFAERS: 66
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
11PruritusFAERS: 54
Canada Vigilance: 1
Canada Vigilance
US FAERS
12Feeling abnormalFAERS: 50US FAERS
13FatigueFAERS: 49
Canada Vigilance: 2
Canada Vigilance
US FAERS
14Intentional product misuseFAERS: 47US FAERS
15Drug ineffectiveFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
16Acute kidney injuryFAERS: 41
Canada Vigilance: 2
Canada Vigilance
US FAERS
17AstheniaFAERS: 41
Canada Vigilance: 2
Canada Vigilance
US FAERS
18Myocardial InfarctionFAERS: 41
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
19VomitingFAERS: 40
Canada Vigilance: 3
Canada Vigilance
US FAERS
20SepsisFAERS: 38
Canada Vigilance: 2
Canada Vigilance
US FAERS
21PancreatitisFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
22InfectionFAERS: 36
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
23PainFAERS: 36
Canada Vigilance: 3
Canada Vigilance
US FAERS
24AlopeciaFAERS: 35US FAERS
25Back PainFAERS: 35
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
26Drug dose omissionFAERS: 34US FAERS
27Product use issueFAERS: 34US FAERS
28Cerebrovascular accidentFAERS: 33
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
29ThirstFAERS: 33
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
30Abdominal PainFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
31DysuriaFAERS: 30SIDER
US FAERS
32ArthralgiaFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
33Blood glucose decreasedFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
34Genital infection fungalFAERS: 28SIDER
US FAERS
35MyalgiaFAERS: 28
Canada Vigilance: 2
Canada Vigilance
US FAERS
36Cerebral InfarctionFAERS: 25US FAERS
37Adverse eventFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
38HypersensitivityFAERS: 23SIDER
US FAERS
39Oropharyngeal painFAERS: 23
Canada Vigilance: 3
Canada Vigilance
US FAERS
40Diabetes mellitus inadequate controlFAERS: 22US FAERS
41Metabolic acidosisFAERS: 22US FAERS
42HypotensionFAERS: 21SIDER
US FAERS
43PyelonephritisFAERS: 19US FAERS
44Vulvovaginal mycotic infectionFAERS: 19
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
45Abdominal discomfortFAERS: 18US FAERS
46Chest PainFAERS: 18US FAERS
47KetonuriaFAERS: 18US FAERS
48Therapy cessationFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
49UrticariaFAERS: 18SIDER
US FAERS
50BalanoposthitisFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
51ConstipationFAERS: 17SIDER
US FAERS
52NephritisFAERS: 17US FAERS
53PolyuriaFAERS: 17
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
54Product use in unapproved indicationFAERS: 17US FAERS
55Renal painFAERS: 17US FAERS
56Blood creatinine increasedFAERS: 15SIDER
US FAERS
57Blood glucose abnormalFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
58Blood urine presentFAERS: 15US FAERS
59NephrolithiasisFAERS: 15US FAERS
60PneumoniaFAERS: 15US FAERS
61SyncopeFAERS: 15US FAERS
62Blood triglycerides increasedFAERS: 14US FAERS
63Euglycaemic diabetic ketoacidosisFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
64Genital rashFAERS: 14US FAERS
65PalpitationsFAERS: 14US FAERS
66SomnolenceFAERS: 13US FAERS
67Urinary IncontinenceFAERS: 13US FAERS
68AnxietyFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
69PhimosisFAERS: 12US FAERS
70SwellingFAERS: 12US FAERS
71Blood glucose fluctuationFAERS: 11US FAERS
72CystitisFAERS: 11US FAERS
73GlycosuriaFAERS: 11US FAERS
74Pancreatic carcinomaFAERS: 11US FAERS
75Visual ImpairmentFAERS: 11US FAERS
76ChillsFAERS: 10US FAERS
77Erectile dysfunctionFAERS: 10US FAERS
78Flank PainFAERS: 10US FAERS
79NasopharyngitisFAERS: 10SIDER
US FAERS
80Peripheral swellingFAERS: 10US FAERS
81TremorFAERS: 10US FAERS
82Vulvovaginal pruritusFAERS: 10SIDER
US FAERS
83ErythemaFAERS: 9US FAERS
84GastroenteritisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
85Genital infectionFAERS: 9US FAERS
86HungerFAERS: 9US FAERS
87Product dose omissionFAERS: 9US FAERS
88Urinary RetentionFAERS: 9US FAERS
89Urine output increasedFAERS: 9SIDER
US FAERS
90Blood cholesterol increasedFAERS: 8US FAERS
91Blood ketone body increasedFAERS: 8US FAERS
92Burning sensationFAERS: 8US FAERS
93Lip swellingFAERS: 8US FAERS
94VertigoFAERS: 8US FAERS
95Blood creatine phosphokinase increasedFAERS: 7US FAERS
96GangreneFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
97Genital painFAERS: 7US FAERS
98InfluenzaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
99NocturiaFAERS: 7SIDER
US FAERS
100SinusitisFAERS: 7US FAERS
101ThrombosisFAERS: 7US FAERS
102Urine ketone body presentFAERS: 7US FAERS
103AcidosisFAERS: 6US FAERS
104Bladder painFAERS: 6US FAERS
105Chest discomfortFAERS: 6US FAERS
106ChromaturiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
107Diabetic FootFAERS: 6US FAERS
108Dry skinFAERS: 6US FAERS
109DysgeusiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
110HypophagiaFAERS: 6US FAERS
111Musculoskeletal PainFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
112PolydipsiaFAERS: 6US FAERS
113Renal cystFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
114Skin UlcerFAERS: 6US FAERS
115TachycardiaFAERS: 6US FAERS
116Atrial FibrillationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
117Blood potassium increasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
118CellulitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
119Circumstance or information capable of leading to medication errorFAERS: 5US FAERS
120DysarthriaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
121Feeling jitteryFAERS: 5US FAERS
122GoutFAERS: 5US FAERS
123IncontinenceFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
124KetosisFAERS: 5US FAERS
125LethargyFAERS: 5US FAERS
126Limb discomfortFAERS: 5US FAERS
127NervousnessFAERS: 5US FAERS
128Renal abscessFAERS: 5US FAERS
129Alanine Aminotransferase IncreasedFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
130Angina PectorisFAERS: 4SIDER
US FAERS
131Blood creatine increasedFAERS: 4US FAERS
132Blood potassium decreasedFAERS: 4US FAERS
133Bowel movement irregularityFAERS: 4US FAERS
134Deep Vein ThrombosisFAERS: 4US FAERS
135DyspepsiaFAERS: 4US FAERS
136EpididymitisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
137Genital discomfortFAERS: 4US FAERS
138Genital swellingFAERS: 4US FAERS
139Incorrect dose administeredFAERS: 4US FAERS
140Memory impairmentFAERS: 4US FAERS
141Mouth swellingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
142Neck PainFAERS: 4US FAERS
143PallorFAERS: 4US FAERS
144Penile InfectionFAERS: 4SIDER
US FAERS
145Penile swellingFAERS: 4US FAERS
146Protein urine presentFAERS: 4US FAERS
147ProteinuriaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
148PsoriasisFAERS: 4US FAERS
149Pulmonary EmbolismFAERS: 4US FAERS
150Septic ShockFAERS: 4US FAERS
151Skin lesionFAERS: 4US FAERS
152ThrombocytopeniaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
153Urinary tract infection fungalFAERS: 4US FAERS
154Vulvovaginal burning sensationFAERS: 4US FAERS
155AbscessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
156Accidental exposure to productFAERS: 3US FAERS
157Acquired phimosisFAERS: 3US FAERS
158Altered state of consciousnessFAERS: 3US FAERS
159AmputationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
160AngioedemaFAERS: 3SIDER
US FAERS
161Apparent deathFAERS: 3US FAERS
162Aspartate Aminotransferase IncreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
163Bladder NeoplasmFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
164Bladder cancer recurrentFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
165Bladder papillomaFAERS: 3US FAERS
166Bladder spasmFAERS: 3US FAERS
167BlindnessFAERS: 3US FAERS
168Blood sodium decreasedFAERS: 3US FAERS
169Blood sodium increasedFAERS: 3US FAERS
170ColitisFAERS: 3US FAERS
171Creatinine renal clearance decreasedFAERS: 3US FAERS
172Diabetes MellitusFAERS: 3SIDER
US FAERS
173Diabetic metabolic decompensationFAERS: 3US FAERS
174DisabilityFAERS: 3US FAERS
175DiscomfortFAERS: 3SIDER
US FAERS
176Escherichia urinary tract infectionFAERS: 3US FAERS
177Food cravingFAERS: 3US FAERS
178Genital burning sensationFAERS: 3US FAERS
179Genital erythemaFAERS: 3US FAERS
180HepatitisFAERS: 3US FAERS
181HypothyroidismFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
182Loss of personal independence in daily activitiesFAERS: 3US FAERS
183LymphadenopathyFAERS: 3US FAERS
184Mental status changesFAERS: 3US FAERS
185MetrorrhagiaFAERS: 3US FAERS
186Musculoskeletal discomfortFAERS: 3US FAERS
187Musculoskeletal stiffnessFAERS: 3US FAERS
188Oral candidiasisFAERS: 3US FAERS
189Oral fungal infectionFAERS: 3US FAERS
190Oral painFAERS: 3US FAERS
191Peripheral arterial occlusive diseaseFAERS: 3US FAERS
192PresyncopeFAERS: 3US FAERS
193Product name confusionFAERS: 3US FAERS
194Respiratory FailureFAERS: 3US FAERS
195RestlessnessFAERS: 3US FAERS
196RhabdomyolysisFAERS: 3US FAERS
197Sexual DysfunctionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
198StomatitisFAERS: 3US FAERS
199StressFAERS: 3US FAERS
200Therapeutic response unexpectedFAERS: 3US FAERS
201Thermal burnFAERS: 3US FAERS
202TinnitusFAERS: 3US FAERS
203ToothacheFAERS: 3US FAERS
204UlcerFAERS: 3US FAERS
205Unresponsive to stimuliFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
206Urine flow decreasedFAERS: 3US FAERS
207VasculitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
208Vulvovaginal drynessFAERS: 3US FAERS
209VulvovaginitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
210Wrong technique in drug usage processFAERS: 3US FAERS
211nervous system disorderFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
212prostatitisFAERS: 3US FAERS
213Acute prerenal failureFAERS: 2US FAERS
214AgitationFAERS: 2US FAERS
215AngerFAERS: 2US FAERS
216AnuriaFAERS: 2US FAERS
217AppendicitisFAERS: 2US FAERS
218ArthritisFAERS: 2US FAERS
219Autoimmune hepatitisFAERS: 2SIDER
US FAERS
220Blood albumin decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
221Blood cholesterol abnormalFAERS: 2US FAERS
222Blood ketone bodyFAERS: 2US FAERS
223Bone density decreasedFAERS: 2US FAERS
224CataractFAERS: 2US FAERS
225CholangitisFAERS: 2US FAERS
226Cholecystitis infectiveFAERS: 2US FAERS
227CholelithiasisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
228ConjunctivitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
229Creatinine renal clearance increasedFAERS: 2US FAERS
230CryingFAERS: 2US FAERS
231CystFAERS: 2US FAERS
232DementiaFAERS: 2US FAERS
233DiplopiaFAERS: 2US FAERS
234DisorientationFAERS: 2US FAERS
235Disseminated Intravascular CoagulationFAERS: 2US FAERS
236DiverticulitisFAERS: 2US FAERS
237Drug level decreasedFAERS: 2US FAERS
238Drug prescribing errorFAERS: 2US FAERS
239DyscheziaFAERS: 2US FAERS
240DyspareuniaFAERS: 2US FAERS
241DysphoniaFAERS: 2US FAERS
242EczemaFAERS: 2US FAERS
243Electrolyte imbalanceFAERS: 2US FAERS
244EructationFAERS: 2US FAERS
245Escherichia infectionFAERS: 2US FAERS
246Extra dose administeredFAERS: 2US FAERS
247FlatulenceFAERS: 2US FAERS
248FlushingFAERS: 2US FAERS
249Foreign body sensation in eyesFAERS: 2US FAERS
250Gastrointestinal PainFAERS: 2US FAERS
251Gastrointestinal carcinomaFAERS: 2US FAERS
252General physical health deteriorationFAERS: 2US FAERS
253Genitourinary tract infectionFAERS: 2US FAERS
254Granuloma AnnulareFAERS: 2US FAERS
255Head discomfortFAERS: 2US FAERS
256HepatomegalyFAERS: 2US FAERS
257HydronephrosisFAERS: 2US FAERS
258IleusFAERS: 2US FAERS
259Inability to afford medicationFAERS: 2US FAERS
260Inappropriate schedule of drug administrationFAERS: 2US FAERS
261Injection site painFAERS: 2US FAERS
262Insurance issueFAERS: 2US FAERS
263Intermittent ClaudicationFAERS: 2US FAERS
264Joint swellingFAERS: 2US FAERS
265Limb injuryFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
266Lipase increasedFAERS: 2US FAERS
267Low density lipoprotein increasedFAERS: 2US FAERS
268Lower Urinary Tract SymptomsFAERS: 2US FAERS
269Medication ErrorFAERS: 2US FAERS
270MicroalbuminuriaFAERS: 2US FAERS
271Multiple SclerosisFAERS: 2US FAERS
272NecrosisFAERS: 2US FAERS
273Night sweatsFAERS: 2US FAERS
274OnychoclasisFAERS: 2US FAERS
275OsteomyelitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
276OverweightFAERS: 2US FAERS
277PemphigusFAERS: 2US FAERS
278Penile erythemaFAERS: 2US FAERS
279Purulent dischargeFAERS: 2US FAERS
280Renal ColicFAERS: 2US FAERS
281Respiratory distressFAERS: 2US FAERS
282Serum SicknessFAERS: 2US FAERS
283ShockFAERS: 2US FAERS
284SluggishnessFAERS: 2US FAERS
285Suprapubic painFAERS: 2US FAERS
286Thrombotic cerebral infarctionFAERS: 2US FAERS
287Tinea crurisFAERS: 2US FAERS
288Upper-airway cough syndromeFAERS: 2US FAERS
289Urethritis noninfectiveFAERS: 2US FAERS
290Ventricular FibrillationFAERS: 2US FAERS
291Vulvovaginal discomfortFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
292Vulvovaginal painFAERS: 2US FAERS
293jaundiceFAERS: 2US FAERS
294AbasiaFAERS: 1US FAERS
295Abdominal tendernessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
296AcarodermatitisFAERS: 1US FAERS
297Accidental exposure to product by childFAERS: 1US FAERS
298Accidental overdoseFAERS: 1US FAERS
299AcneFAERS: 1US FAERS
300Acute Coronary SyndromeFAERS: 1SIDER
US FAERS
301Acute cardiac eventFAERS: 1US FAERS
302AkinesiaFAERS: 1US FAERS
303Albumin globulin ratio decreasedFAERS: 1US FAERS
304AlbuminuriaFAERS: 1US FAERS
305Alcohol IntoleranceFAERS: 1US FAERS
306AmnesiaFAERS: 1US FAERS
307Anaphylactic shockFAERS: 1SIDER
US FAERS
308AneurysmFAERS: 1US FAERS
309Animal biteFAERS: 1US FAERS
310Anion GapFAERS: 1US FAERS
311Ankle FractureFAERS: 1US FAERS
312ApathyFAERS: 1US FAERS
313AphoniaFAERS: 1US FAERS
314Arterial thrombosisFAERS: 1US FAERS
315ArthropathyFAERS: 1US FAERS
316Arthropod biteFAERS: 1US FAERS
317AscitesFAERS: 1US FAERS
318Autoimmune PancreatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
319Autoimmune thyroiditisFAERS: 1US FAERS
320Bacterial VaginosisFAERS: 1US FAERS
321Benign NeoplasmFAERS: 1US FAERS
322Benign neoplasm of thyroid glandFAERS: 1US FAERS
323Bipolar DisorderFAERS: 1US FAERS
324Bladder cystFAERS: 1US FAERS
325Bladder discomfortFAERS: 1US FAERS
326Bladder transitional cell carcinoma stage IFAERS: 1US FAERS
327BlepharitisFAERS: 1US FAERS
328Blood alkaline phosphatase increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
329Blood creatinine decreasedFAERS: 1US FAERS
330Blood electrolytes decreasedFAERS: 1US FAERS
331Blood insulin decreasedFAERS: 1US FAERS
332Blood magnesium decreasedFAERS: 1US FAERS
333Blood pH decreasedFAERS: 1US FAERS
334Blood phosphorus decreasedFAERS: 1US FAERS
335Blood pressure fluctuationFAERS: 1SIDER
US FAERS
336Blood urea increasedFAERS: 1SIDER
US FAERS
337Bone lesionFAERS: 1US FAERS
338Bone painFAERS: 1US FAERS
339BradycardiaFAERS: 1US FAERS
340Brain ContusionFAERS: 1US FAERS
341BronchitisFAERS: 1US FAERS
342Carbon dioxide decreasedFAERS: 1US FAERS
343Cardiac ArrestFAERS: 1US FAERS
344Cardiac FlutterFAERS: 1US FAERS
345Cellulitis of male external genital organFAERS: 1US FAERS
346Cerebral disorderFAERS: 1US FAERS
347Cervix carcinomaFAERS: 1US FAERS
348CheilitisFAERS: 1US FAERS
349CholecystitisFAERS: 1US FAERS
350Cold sweatFAERS: 1US FAERS
351Completed SuicideFAERS: 1US FAERS
352Contraindicated drug administeredFAERS: 1US FAERS
353Contraindicated product administeredFAERS: 1US FAERS
354Corneal OpacityFAERS: 1US FAERS
355Coronary Artery DiseaseFAERS: 1US FAERS
356Crystal urine presentFAERS: 1US FAERS
357Deafness PermanentFAERS: 1US FAERS
358DeafnessFAERS: 1US FAERS
359DeliriumFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
360Dental PlaqueFAERS: 1US FAERS
361Dental cariesFAERS: 1US FAERS
362Depressed Level of ConsciousnessFAERS: 1US FAERS
363DermatitisFAERS: 1SIDER
US FAERS
364Device computer issueFAERS: 1US FAERS
365Diabetic NephropathyFAERS: 1US FAERS
366Disease ProgressionFAERS: 1US FAERS
367Diverticular fistulaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
368Drug administered to patient of inappropriate ageFAERS: 1US FAERS
369Drug administration errorFAERS: 1US FAERS
370Drug dispensing errorFAERS: 1US FAERS
371Drug level fluctuatingFAERS: 1US FAERS
372Drug monitoring procedure incorrectly performedFAERS: 1US FAERS
373Drug withdrawal syndromeFAERS: 1US FAERS
374Dry gangreneFAERS: 1US FAERS
375Duodenal ulcer perforationFAERS: 1US FAERS
376DysphemiaFAERS: 1US FAERS
377DystoniaFAERS: 1US FAERS
378Electrolyte depletionFAERS: 1US FAERS
379EmbolismFAERS: 1US FAERS
380Emotional disorderFAERS: 1US FAERS
381Emotional distressFAERS: 1US FAERS
382Emphysematous cystitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
383Emphysematous pyelonephritisFAERS: 1US FAERS
384EnteritisFAERS: 1US FAERS
385EnuresisFAERS: 1US FAERS
386EosinophiliaFAERS: 1US FAERS
387EpilepsyFAERS: 1US FAERS
388EpistaxisFAERS: 1US FAERS
389Erythema MultiformeFAERS: 1US FAERS
390Escherichia sepsisFAERS: 1US FAERS
391Euphoric moodFAERS: 1US FAERS
392Extremity necrosisFAERS: 1US FAERS
393Eye InfectionFAERS: 1US FAERS
394Facial PainFAERS: 1US FAERS
395Facial paralysisFAERS: 1US FAERS
396FasciitisFAERS: 1US FAERS
397Fibroadenoma of breastFAERS: 1US FAERS
398FibromyalgiaFAERS: 1US FAERS
399Fixed drug eruptionFAERS: 1US FAERS
400Fluid replacementFAERS: 1US FAERS
401FolliculitisFAERS: 1US FAERS
402Food PoisoningFAERS: 1US FAERS
403FractureFAERS: 1SIDER
US FAERS
404Frustration tolerance decreasedFAERS: 1US FAERS
405Full blood count abnormalFAERS: 1US FAERS
406Fungal cystitisFAERS: 1US FAERS
407Gastric ulcerFAERS: 1US FAERS
408GastritisFAERS: 1US FAERS
409Gastrointestinal infectionFAERS: 1US FAERS
410Genital HerpesFAERS: 1US FAERS
411Genital abscessFAERS: 1US FAERS
412Gingival discomfortFAERS: 1US FAERS
413Gluten sensitivityFAERS: 1US FAERS
414Groin infectionFAERS: 1US FAERS
415HaemoconcentrationFAERS: 1US FAERS
416Hepatitis EFAERS: 1US FAERS
417Hyperosmolar stateFAERS: 1US FAERS
418HypersomniaFAERS: 1US FAERS
419Hypertensive crisisFAERS: 1US FAERS
420HyperthyroidismFAERS: 1US FAERS
421HypohidrosisFAERS: 1US FAERS
422HypopituitarismFAERS: 1US FAERS
423Immune thrombocytopenic purpuraFAERS: 1US FAERS
424Impaired insulin secretionFAERS: 1US FAERS
425Impaired self-careFAERS: 1US FAERS
426IncoherentFAERS: 1US FAERS
427Incorrect route of drug administrationFAERS: 1US FAERS
428InflammationFAERS: 1US FAERS
429Injection site erythemaFAERS: 1US FAERS
430Injection site massFAERS: 1US FAERS
431Injection site pruritusFAERS: 1US FAERS
432Intentional product use issueFAERS: 1US FAERS
433Intercepted medication errorFAERS: 1US FAERS
434Intercepted product selection errorFAERS: 1US FAERS
435Intestinal ObstructionFAERS: 1US FAERS
436LacerationFAERS: 1US FAERS
437LazinessFAERS: 1US FAERS
438Libido disorderFAERS: 1US FAERS
439Lichen PlanusFAERS: 1US FAERS
440Lip exfoliationFAERS: 1US FAERS
441Lipase abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
442Locked-In SyndromeFAERS: 1US FAERS
443Lower respiratory tract infectionFAERS: 1US FAERS
444Lupus NephritisFAERS: 1US FAERS
445Mechanical ventilation complicationFAERS: 1US FAERS
446Meniscus injuryFAERS: 1US FAERS
447Mental impairmentFAERS: 1US FAERS
448Metastases to abdominal cavityFAERS: 1US FAERS
449Middle insomniaFAERS: 1US FAERS
450Monogenic diabetesFAERS: 1US FAERS
451MonoplegiaFAERS: 1US FAERS
452Mood swingsFAERS: 1US FAERS
453Muscle FatigueFAERS: 1US FAERS
454Muscle RigidityFAERS: 1US FAERS
455Muscle tightnessFAERS: 1US FAERS
456Musculoskeletal chest painFAERS: 1US FAERS
457Myasthenia GravisFAERS: 1US FAERS
458Nasal inflammationFAERS: 1US FAERS
459Needle issueFAERS: 1US FAERS
460Nerve injuryFAERS: 1US FAERS
461NeuralgiaFAERS: 1US FAERS
462No adverse eventFAERS: 1US FAERS
463Nonspecific reactionFAERS: 1US FAERS
464Nuchal RigidityFAERS: 1US FAERS
465ObesityFAERS: 128807765CTD
US FAERS
466Oral mucosal eruptionFAERS: 1US FAERS
467OrchitisFAERS: 1US FAERS
468Oropharyngeal discomfortFAERS: 1US FAERS
469OverdoseFAERS: 1US FAERS
470Pain of skinFAERS: 1US FAERS
471Painful ejaculationFAERS: 1US FAERS
472PancytopeniaFAERS: 1US FAERS
473Pelvic PainFAERS: 1US FAERS
474Perforated ulcerFAERS: 1US FAERS
475Pericardial effusionFAERS: 1US FAERS
476Perineal infectionFAERS: 1US FAERS
477Perineal painFAERS: 1US FAERS
478PeritonitisFAERS: 1US FAERS
479Personality ChangeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
480Pleural MesotheliomaFAERS: 1US FAERS
481PolyarthritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
482Poor quality sleepFAERS: 1US FAERS
483Post procedural cellulitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
484Postrenal failureFAERS: 1US FAERS
485Procalcitonin increasedFAERS: 1US FAERS
486Product administered to patient of inappropriate ageFAERS: 1US FAERS
487Product packaging quantity issueFAERS: 1US FAERS
488Product quality issueFAERS: 1US FAERS
489PrurigoFAERS: 1US FAERS
490Pulmonary FibrosisFAERS: 1US FAERS
491Pulmonary thrombosisFAERS: 1US FAERS
492PurpuraFAERS: 1US FAERS
493Quality of life decreasedFAERS: 1US FAERS
494Rash erythematousFAERS: 1US FAERS
495Rectal abscessFAERS: 1US FAERS
496Renal massFAERS: 1US FAERS
497Renal tubular necrosisFAERS: 1US FAERS
498Respiratory tract congestionFAERS: 1US FAERS
499Restless Legs SyndromeFAERS: 1US FAERS
500Scrotal InfectionFAERS: 1US FAERS
501Secretion dischargeFAERS: 1US FAERS
502Sinus TachycardiaFAERS: 1US FAERS
503Skin irritationFAERS: 1US FAERS
504Skin tightnessFAERS: 1US FAERS
505Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
506SneezingFAERS: 1US FAERS
507StarvationFAERS: 1US FAERS
508Strangulated herniaFAERS: 1US FAERS
509Sudden deathFAERS: 1US FAERS
510Suicide attemptFAERS: 1US FAERS
511Suspected counterfeit productFAERS: 1US FAERS
512T-Cell LymphomaFAERS: 1US FAERS
513TalipesFAERS: 1US FAERS
514Testicular massFAERS: 1US FAERS
515Therapy changeFAERS: 1US FAERS
516Therapy non-responderFAERS: 1US FAERS
517Throat irritationFAERS: 1US FAERS
518Thyroid NeoplasmFAERS: 1US FAERS
519Thyroid hormones decreasedFAERS: 1US FAERS
520Tongue discomfortFAERS: 1US FAERS
521TonsillitisFAERS: 1US FAERS
522Transcription medication errorFAERS: 1US FAERS
523TrichorrhexisFAERS: 1US FAERS
524Unevaluable eventFAERS: 1US FAERS
525Urge IncontinenceFAERS: 1US FAERS
526Uterine cervix ulcerFAERS: 1US FAERS
527VIIth nerve paralysisFAERS: 1US FAERS
528Vaginal DischargeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
529Vaginal cellulitisFAERS: 1US FAERS
530Vaginal lesionFAERS: 1US FAERS
531Vascular occlusionFAERS: 1US FAERS
532Vitreous DetachmentFAERS: 1US FAERS
533Vulvovaginal swellingFAERS: 1US FAERS
534White blood cell count decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
535Wound InfectionFAERS: 1US FAERS
536carbuncleFAERS: 1US FAERS
537furuncleFAERS: 1US FAERS
538liposarcomaFAERS: 1US FAERS
539skin abrasionFAERS: 1US FAERS
540Anion gap abnormalCanada Vigilance: 1Canada Vigilance
541BalanitisSIDER
542Blood glucose normalCanada Vigilance: 1Canada Vigilance
543Carbon dioxide abnormalCanada Vigilance: 1Canada Vigilance
544CarcinogenicitySIDER
545Cognition Disorders28807765CTD
546DiuresisSIDER
547Hyperglycemia30551545CTD
548Incorrect route of product administrationCanada Vigilance: 1Canada Vigilance
549InfestationSIDER
550Insulin Resistance28807765CTD
551MalnutritionSIDER
552OsteopeniaSIDER
553Periorbital swellingCanada Vigilance: 1Canada Vigilance
554VulvitisCanada Vigilance: 1Canada Vigilance
SIDER
555Weight Gain28807765CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.